These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 12531084

  • 1. Prevention of bronchiolitis.
    Pringle CR.
    Paediatr Respir Rev; 2000 Sep; 1(3):228-34. PubMed ID: 12531084
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention strategies for respiratory syncytial virus: passive and active immunization.
    Englund JA.
    J Pediatr; 1999 Aug; 135(2 Pt 2):38-44. PubMed ID: 10431138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.
    Rev Med Virol; 2007 Aug; 17(1):5-34. PubMed ID: 17004293
    [Abstract] [Full Text] [Related]

  • 6. Respiratory syncytial virus immune globulin: decisions and costs.
    Barton LL, Grant KL, Lemen RJ.
    Pediatr Pulmonol; 2001 Jul; 32(1):20-8. PubMed ID: 11416872
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advances in the treatment and prevention of severe viral bronchiolitis.
    Domachowske JB, Rosenberg HF.
    Pediatr Ann; 2005 Jan; 34(1):35-41. PubMed ID: 15693214
    [Abstract] [Full Text] [Related]

  • 13. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [Abstract] [Full Text] [Related]

  • 14. Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab.
    Fitzgerald DA.
    Paediatr Respir Rev; 2009 Sep; 10(3):143-7. PubMed ID: 19651385
    [Abstract] [Full Text] [Related]

  • 15. Respiratory syncytial virus infections: recent prospects for control.
    Sidwell RW, Barnard DL.
    Antiviral Res; 2006 Sep; 71(2-3):379-90. PubMed ID: 16806515
    [Abstract] [Full Text] [Related]

  • 16. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
    Cardenas S, Auais A, Piedimonte G.
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):719-26. PubMed ID: 16207163
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.
    Reeve CA, Whitehall JS, Buettner PG, Norton R, Reeve DM, Francis F.
    J Paediatr Child Health; 2006 May; 42(5):253-8. PubMed ID: 16712554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human and bovine respiratory syncytial virus vaccine research and development.
    Meyer G, Deplanche M, Schelcher F.
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):191-225. PubMed ID: 17720245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.